Found 3298 clinical trials
COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.
This investigational study is enrolling moderate to severe COPD subjects. To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year. Pulmonary function test will be performed and compensation will be provided for those who qualify.
- 147 views
- 23 Nov, 2020
- 1 location
Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype
A study for patients with severe asthma currently treated with injectable medication (benralizumab or mepolizumab) to see if the study medication can improve lung function and decrease the
- 0 views
- 07 Jul, 2022
- 1 location
Eosinophilic Asthma Research Study
Qualified participants will not be charged to receive:• Study medicine and study-related office visits • Study-related ECG, lung function tests, and lab work • You may be compensated for time
- 3 views
- 21 Dec, 2021
- 1 location
EF-36
-3475) in subjects previously untreated for their advance or metastatic intrathoracic, PD-L1 positive (TPS≥1% [tumor proportion score]) non-small cell lung cancer (NSCLC).
- 0 views
- 25 Aug, 2023
- 1 location
Asthma Sample Collection Protocol
Fiberoptic bronchoscopy is a procedure which involves passing a pencil-thin tube into the lung in order to collect fluid and cells from the airways. Fiberoptic bronchoscopy can collect cells from
- 335 views
- 23 Nov, 2020
- 1 location
COPD Exacerbation Research Study
Looking for patients at least 40 years of age who have been diagnosed with COPD and recently had several events of worsening of symptoms.
- 133 views
- 23 Nov, 2020
- 1 location
NO 0050-0637
ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being
- 613 views
- 23 Nov, 2020
- 1 location
Add on treatment for COPD for patients who experience frequent exacerbations
Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple inhaler medications may qualify for this study involving benralizumab subcutaneous injections compared to placebo injections, initially every 4 weeks, then every 8 weeks …
- 0 views
- 09 Jun, 2022
- 1 location
Moderate to Severe COPD
Phase: IIITime Frame: 18 monthsAge requirements: 40 to 85 years of age
- 0 views
- 05 Sep, 2023
- 1 location
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.
- 37 views
- 27 Dec, 2022
- 202 locations